Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/30/2025

Oxybutynin Treatment for Overactive Bladder

Patient Selection and Dosing

  • Age alone does not modify clinical outcomes, as high-quality evidence shows oxybutynin effectively improves urinary incontinence and quality of life in older women 1
  • For children with neurogenic bladder, oxybutynin can be used at a dose of 0.2 mg/kg three times daily 2

Treatment Considerations

  • Oxybutynin should be used as second-line therapy only after behavioral interventions have been attempted, according to the American Urological Association 4
  • Behavioral therapies are strongly recommended as first-line treatment for all patients with overactive bladder 4
  • Absolute contraindications for oxybutynin include narrow-angle glaucoma, impaired gastric emptying, and history of urinary retention 4
  • The American Urological Association recommends considering post-void residual assessment before initiating therapy in patients at higher risk of urinary retention 4
  • Exclude or treat constipation before starting anticholinergic therapy, as recommended by the American Urological Association 5

Alternative Therapies

  • If oxybutynin is poorly tolerated, consider solifenacin, which has the lowest risk for discontinuation due to adverse effects among antimuscarinics 4
  • Fesoterodine has superior efficacy to tolterodine for achieving continence, with a number needed to benefit of 18 1

Treatment Duration and Reassessment

  • Reassess patients after 4-8 weeks to evaluate treatment efficacy, as recommended by the American Urological Association 6
  • If standard treatment fails after 2 months, consider combination therapy with desmopressin or third-line treatments 5